No Prescription |
 |
 | ||
|
FASIGYN Tindamax |
|
| ||
No Prescription » Prescription Drugs 7 » FASIGYN Tindamax Tinidazole is used to treat trichomoniasis (a sexually transmitted disease that can affect men and women) giardiasis (an infection of the intestine that can cause diarrhea gas and stomach cramps) and amebiasis (an infection of the intestine that can cause diarrhea gas and stomach cramps and can spread to other organs such as the liver). Tinidazole is in a class of medications called antiprotozoal agents. It works by killing the organisms that can cause infection.Tinidazole comes as a suspension (liquid) prepared by the pharmacist and a tablet to take by mouth. It is usually taken with food as a single dose or once a day for 3 to 5 days. To help you remember to take tinidazole (if you are to take it for more than one day) take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take tinidazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use to mix the medication evenly.Take tinidazole until you finish the prescription even if you feel better. If you stop taking tinidazole too soon or skip doses your infection may not be completely cured and bacteria may become resistant to antibiotics Buy FASIGYN Tindamax and other Prescription Drugs 7 products online at Medstore. 519
About FASIGYN Tindamax: Product Type: Prescription Drugs 7 FASIGYN ( Tindamax Generic Tinidazole ) FASIGYN (Tindamax Generic Tinidazole) Tindamax Generic Tinidazole 500mg Tabs 16 (4 x 4) Tindamax Generic Tinidazole FASIGYN
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
